UBS Group’s Adient ADNT Stock Holding History
Bought
Maintained
Sold
Other funds holding ADNT
HHAM
UBS Group's ADNT Position: Q2 2026 in Review
UBS Group reduced its Adient (ADNT) stake by 12% in Q2 2026, selling an estimated $4.77M and leaving 1,703,353 shares worth $31.3M. The position accounts for ﹤0.01% of the portfolio, ranked #2227.
UBS Group first reported a position in ADNT in Q4 2016 and has held it in 39 quarters since. The position peaked at $77.2M in Q1 2018. 313 funds tracked by Wall St. Rank hold ADNT as of Q2 2026.
- UBS Group held 1,703,353 shares of Adient worth $31.3M as of Q2 2026.
- UBS Group sold 223,256 Adient shares in Q2 2026, an estimated $4.77M.
- Adient made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #2227 holding.
- UBS Group first reported a position in Adient in Q4 2016 and has held it in 39 quarters since.
- UBS Group's Adient position peaked at $77.2M in Q1 2018.
- 313 funds tracked by Wall St. Rank held Adient as of Q2 2026.
Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.